Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Quality of Life for Subjects Receiving Androgen Deprivation Therapy and Have a Doubling in PSA of Either Less Than or Greater Than 1 Year

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2009 by Urology South Shore Research Inc..
Recruitment status was  Recruiting
Sponsor:
Collaborator:
AstraZeneca
Information provided by:
Urology South Shore Research Inc.
ClinicalTrials.gov Identifier:
NCT00703768
First received: June 19, 2008
Last updated: February 13, 2009
Last verified: February 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: July 2010
  Estimated Primary Completion Date: June 2010 (Final data collection date for primary outcome measure)